JP2022064912A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022064912A5 JP2022064912A5 JP2022005112A JP2022005112A JP2022064912A5 JP 2022064912 A5 JP2022064912 A5 JP 2022064912A5 JP 2022005112 A JP2022005112 A JP 2022005112A JP 2022005112 A JP2022005112 A JP 2022005112A JP 2022064912 A5 JP2022064912 A5 JP 2022064912A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- composition
- salt
- muscle
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 35
- 150000003839 salts Chemical class 0.000 claims 16
- 241000124008 Mammalia Species 0.000 claims 14
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical group C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims 10
- 102000008934 Muscle Proteins Human genes 0.000 claims 10
- 108010074084 Muscle Proteins Proteins 0.000 claims 10
- -1 nitrogen-containing organic acid Chemical class 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 238000001243 protein synthesis Methods 0.000 claims 9
- 210000002027 skeletal muscle Anatomy 0.000 claims 9
- 230000014616 translation Effects 0.000 claims 9
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 8
- 150000001413 amino acids Chemical class 0.000 claims 8
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 6
- 239000011230 binding agent Substances 0.000 claims 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims 6
- 239000000194 fatty acid Substances 0.000 claims 6
- 229930195729 fatty acid Natural products 0.000 claims 6
- 239000003381 stabilizer Substances 0.000 claims 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 5
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 229960003624 creatine Drugs 0.000 claims 4
- 239000006046 creatine Substances 0.000 claims 4
- 150000004665 fatty acids Chemical class 0.000 claims 4
- 210000003205 muscle Anatomy 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 230000001965 increasing effect Effects 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 230000037081 physical activity Effects 0.000 claims 3
- 239000000377 silicon dioxide Substances 0.000 claims 3
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 claims 2
- 239000001904 Arabinogalactan Substances 0.000 claims 2
- 229920000189 Arabinogalactan Polymers 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- 229920000084 Gum arabic Polymers 0.000 claims 2
- 239000005913 Maltodextrin Substances 0.000 claims 2
- 229920002774 Maltodextrin Polymers 0.000 claims 2
- 241000978776 Senegalia senegal Species 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- 239000000205 acacia gum Substances 0.000 claims 2
- 235000010489 acacia gum Nutrition 0.000 claims 2
- 235000019312 arabinogalactan Nutrition 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 229940035034 maltodextrin Drugs 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 claims 1
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 150000003862 amino acid derivatives Chemical class 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims 1
- 235000013539 calcium stearate Nutrition 0.000 claims 1
- 239000008116 calcium stearate Substances 0.000 claims 1
- 150000001734 carboxylic acid salts Chemical class 0.000 claims 1
- 229960004203 carnitine Drugs 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 208000001076 sarcopenia Diseases 0.000 claims 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562269573P | 2015-12-18 | 2015-12-18 | |
| US62/269,573 | 2015-12-18 | ||
| US201562273880P | 2015-12-31 | 2015-12-31 | |
| US62/273,880 | 2015-12-31 | ||
| PCT/US2016/067238 WO2017106687A1 (en) | 2015-12-18 | 2016-12-16 | Method and composition for increasing muscle protein synthesis and/or functional strength in mammals as well as method of producing a composition |
| JP2018532036A JP2018537987A (ja) | 2015-12-18 | 2016-12-16 | 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018532036A Division JP2018537987A (ja) | 2015-12-18 | 2016-12-16 | 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022064912A JP2022064912A (ja) | 2022-04-26 |
| JP2022064912A5 true JP2022064912A5 (enExample) | 2022-08-31 |
Family
ID=57910110
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018532036A Withdrawn JP2018537987A (ja) | 2015-12-18 | 2016-12-16 | 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法 |
| JP2022005112A Pending JP2022064912A (ja) | 2015-12-18 | 2022-01-17 | 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018532036A Withdrawn JP2018537987A (ja) | 2015-12-18 | 2016-12-16 | 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10888571B2 (enExample) |
| EP (1) | EP3389385A1 (enExample) |
| JP (2) | JP2018537987A (enExample) |
| BR (1) | BR112018012410B1 (enExample) |
| CA (1) | CA3008033A1 (enExample) |
| WO (1) | WO2017106687A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017106687A1 (en) * | 2015-12-18 | 2017-06-22 | Lonza Inc. | Method and composition for increasing muscle protein synthesis and/or functional strength in mammals as well as method of producing a composition |
| JP7529566B2 (ja) | 2017-11-02 | 2024-08-06 | バイオベンチャーズ・リミテッド・ライアビリティ・カンパニー | 筋タンパク質合成を改善するためのアミノ酸補給の使用 |
| CA3132384C (en) * | 2019-03-06 | 2023-09-12 | Xianfeng PENG | Use of .gamma.-quaternary ammonium butyrate compound in preparation of animal feed additive |
| WO2021076926A1 (en) * | 2019-10-16 | 2021-04-22 | Capsugel Belgium Nv | Method and composition for increasing muscle protein synthesis |
| CA3153332A1 (en) * | 2019-10-16 | 2021-04-22 | Aouatef Bellamine | Method and composition for increasing muscle protein synthesis |
| DE102022114966A1 (de) | 2022-06-14 | 2023-12-14 | Alzchem Trostberg Gmbh | Wasserlösliches Kreatin-Agglomerat |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4687782A (en) | 1984-12-10 | 1987-08-18 | Nutri-Fuels Systems, Inc. | Nutritional composition for enhancing skeletal muscle adaptation to exercise training |
| US4883672A (en) | 1988-04-29 | 1989-11-28 | Shug Austin L | Method for preventing diet induced carnitine deficiency in domesticated dogs and cats |
| AU3086897A (en) * | 1996-06-28 | 1998-01-21 | Ipr-Institute For Pharmaceutical Research Ag | Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc |
| US6232346B1 (en) * | 1997-03-27 | 2001-05-15 | Michael J. Sole | Composition for improvement of cellular nutrition and mitochondrial energetics |
| IT1291127B1 (it) | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica |
| US6159942A (en) | 1998-06-19 | 2000-12-12 | Bioenergy, Inc. | Compositions for increasing energy in vivo |
| IT1306173B1 (it) | 1999-07-23 | 2001-05-30 | Sigma Tau Healthscience Spa | Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare. |
| WO2001058271A1 (en) | 2000-01-25 | 2001-08-16 | Juvenon, Inc. | Nutritional supplements for aged pets |
| US20030138547A1 (en) | 2002-01-22 | 2003-07-24 | Mars, Incorporated | Weight management system for animals |
| ES2436181T3 (es) | 2004-12-29 | 2013-12-27 | Hill's Pet Nutrition Inc. | Métodos para inhibir un declive en el aprendizaje y/o la memoria en animales |
| US7645742B2 (en) * | 2005-06-22 | 2010-01-12 | Advocare International, L.P. | Composition for enhancing cellular energy |
| US20080085343A1 (en) * | 2006-09-14 | 2008-04-10 | Petty Holly T | Novel Low Allergenic Food Bar |
| WO2008115563A1 (en) * | 2007-03-19 | 2008-09-25 | University Of Florida Research Foundation, Inc. | Liquid nutrient composition for improving performance |
| US7790688B2 (en) * | 2008-01-11 | 2010-09-07 | Healthspan Solutions, Llc | Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly |
| US8546369B2 (en) | 2008-05-30 | 2013-10-01 | Northern Innovations Holding Corp. | Salts of creatine imino sugar amides |
| FR2938733A1 (fr) | 2008-11-21 | 2010-05-28 | Holymark | Composition administrable par voie orale,en particulier pour personne pratiquant une activite physique et complement alimentaire renfermant une telle composition |
| US8784844B2 (en) | 2009-09-30 | 2014-07-22 | Lonza Ltd. | Arabinogalactan for enhancing the adaptive immune response |
| BR112013028723A2 (pt) | 2011-05-10 | 2016-08-09 | Nestec Sa | métodos e composições para promover o crescimento da massa corporal magra |
| ITTO20121098A1 (it) | 2012-12-18 | 2014-06-19 | Univ Degli Studi Genova | Procedimento per sintetizzare derivati della creatina |
| EP3091859A1 (en) * | 2013-12-18 | 2016-11-16 | Abbott Laboratories | Methods for increasing skeletal muscle protein synthesis using green tea extract |
| US10016382B2 (en) | 2014-06-12 | 2018-07-10 | Lonza Inc. | Method for decreasing skeletal muscle damage and/or oxidative stress in mammals |
| WO2017106687A1 (en) * | 2015-12-18 | 2017-06-22 | Lonza Inc. | Method and composition for increasing muscle protein synthesis and/or functional strength in mammals as well as method of producing a composition |
-
2016
- 2016-12-16 WO PCT/US2016/067238 patent/WO2017106687A1/en not_active Ceased
- 2016-12-16 CA CA3008033A patent/CA3008033A1/en active Pending
- 2016-12-16 JP JP2018532036A patent/JP2018537987A/ja not_active Withdrawn
- 2016-12-16 EP EP16831665.1A patent/EP3389385A1/en not_active Withdrawn
- 2016-12-16 US US15/381,731 patent/US10888571B2/en active Active
- 2016-12-16 BR BR112018012410-9A patent/BR112018012410B1/pt not_active IP Right Cessation
-
2021
- 2021-01-08 US US17/144,556 patent/US20210205334A1/en not_active Abandoned
-
2022
- 2022-01-17 JP JP2022005112A patent/JP2022064912A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022064912A5 (enExample) | ||
| JP5227021B2 (ja) | 飼料添加剤としてのグアニジノ酢酸 | |
| US6855727B2 (en) | Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect | |
| US8466187B2 (en) | Amino acid compositions | |
| JP5911806B2 (ja) | カルニチン顆粒およびその製造方法 | |
| JP2018537987A5 (enExample) | ||
| US9238024B2 (en) | Methods for improving health in canines | |
| JP2024122087A (ja) | 遊離アミノ酸吸収促進剤及び遊離アミノ酸の吸収を促進する方法 | |
| JP2022064912A (ja) | 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法 | |
| CN108308493A (zh) | 一种含虾青素的抗疲劳固体饮料及制备方法 | |
| JP6441825B2 (ja) | フィラーの効能維持用組成物 | |
| JP4928473B2 (ja) | グアニジノ酢酸の塩、付加化合物及び錯化合物 | |
| JPH0331211A (ja) | 腎不全のための栄養組成物 | |
| SK115399A3 (en) | Process for the preparation of stable, non-hygroscopic salts of l(-)carnitine and alkanoyl l(-)carnitines | |
| PT1355540E (pt) | Suplemento alimentar com efeito de emagrecimento | |
| JP5689458B2 (ja) | グルコサミンを包含する栄養補助食品を安定化させる方法 | |
| RS52129B (sr) | Dijetetski dodatak koji obezbeđuje energiju skeletnim mišićima i štiti kardiovaskularni trakt | |
| JP2002338473A (ja) | 抗疲労組成物 | |
| JP4873778B2 (ja) | 抗疲労剤 | |
| JP7069531B2 (ja) | ピロロキノリンキノン又はその塩と分岐鎖アミノ酸とを含むカプセル | |
| JP7167287B2 (ja) | 圧縮成型製剤 | |
| JP2021536494A (ja) | マグネシウム含有製剤及びその使用 | |
| JP7781309B2 (ja) | ウイルス感染後疲労症候群治療に用いるためのクレアチンを含む組成物 | |
| US20060292216A1 (en) | Enteric delivery of (-)-hydroxycitric acid | |
| JP2000516937A (ja) | 運動時の酸素消費を低下するビタミン製剤 |